KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Notes Payables: 2020-2024

Historic Notes Payables for BeOne Medicines (ONC) over the last 2 years, with Dec 2024 value amounting to $851.5 million.

  • BeOne Medicines' Notes Payables was N/A to $813.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.3 million, marking a year-over-year change of. This contributed to the annual value of $851.5 million for FY2024, which is N/A change from last year.
  • Per BeOne Medicines' latest filing, its Notes Payables stood at $851.5 million for FY2024, which was up 154.18% from $335.0 million recorded in FY2020.
  • In the past 5 years, BeOne Medicines' Notes Payables ranged from a high of $851.5 million in FY2024 and a low of $335.0 million during FY2020.
  • Its 1-year average for Notes Payables is $851.5 million, with a median of $851.5 million in 2024.